Ligand · CK9
CK9 · 2-{[(2-{[(1R)-1-(hydroxymethyl)propyl]amino}-9-isopropyl-9H-purin-6-yl)amino]methyl}phenol
CK9, 2-{[(2-{[(1R)-1-(hydroxymethyl)propyl]amino}-9-isopropyl-9H-purin-6-yl)amino]methyl}phenol (C19 H26 N6 O2, 370.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues…
- Component
- CK9
- Formula
- C19 H26 N6 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
CK9 in 2 structures; the first of them:
- 2A0C · Human CDK2 in complex with olomoucine II, a novel 2,6,9-trisubstituted purine… · CK9 X500 · binds GLU8, ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, VAL64 and 13 more
- 2A0C · Human CDK2 in complex with olomoucine II, a novel 2,6,9- trisubstituted purine… · CK9 X500 · binds GLU8, ILE10, GLY11, GLU12, GLY13, VAL18, ALA31, VAL64 and 13 more
Residues it binds most
GLU 2, ALA 2, ASP 2, GLN 2, GLY 2, LEU 2, PHE 2, VAL 2, ASN 2, HIS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.